개 아토피 피부염 시장 규모, 점유율 및 성장 분석 : 치료법별, 투여 경로별, 유통 채널별, 질환 중증도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Canine Atopic Dermatitis Market size was valued at USD 2.9 Billion in 2024 and is poised to grow from USD 3.13 Billion in 2025 to USD 5.8 Billion by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).

The global canine atopic dermatitis market is experiencing robust growth fueled by several factors, including the rising trend of pet humanization and the increasing incidence of allergic skin disorders in dogs. Pet owners are becoming more conscious of their pets' health, leading to heightened spending on companion animal healthcare and a growing demand for long-term treatment options. Advancements in dermatology therapies and improved veterinary diagnostics are paving the way for innovative targeted therapies, including monoclonal antibodies and advanced topical formulations. However, challenges such as high treatment costs, limited awareness in specific regions, and compliance issues may hinder market penetration. As pet ownership expands in developing regions and veterinary-pharmaceutical collaboration strengthens, substantial opportunities for market growth are anticipated.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Atopic Dermatitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Canine Atopic Dermatitis Market Segments Analysis

Global canine atopic dermatitis market is segmented by treatment type, route of administration, distribution channel, disease severity, end-user, and region. Based on treatment type, the market is segmented into corticosteroids, cyclosporine, monoclonal antibodies, antihistamines, immunotherapy, and others. Based on route of administration, the market is segmented into oral, injectable, and topical. Based on distribution channel, the market is segmented into veterinary clinics & hospitals, retail pharmacies, and online pharmacies. Based on disease severity, the market is segmented into mild, moderate, and severe. Based on end-user, the market is segmented into veterinary clinics, pet owners, and veterinary hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Canine Atopic Dermatitis Market

The Global Canine Atopic Dermatitis market is experiencing significant growth due to the increasing number of pet owners and shifting attitudes towards pet care in domestic environments. As awareness regarding atopic conditions rises, pet owners are more proactive in seeking veterinary treatment for their dogs, viewing them as integral family members. This trend encourages consultations with veterinary professionals and adherence to their recommendations, further fueling market growth. In response, veterinary practices are enhancing their testing and management offerings, while private sector companies are driven to innovate new products and disseminate information more widely, thereby supporting the overall expansion of this market.

Restraints in the Global Canine Atopic Dermatitis Market

The Global Canine Atopic Dermatitis market faces significant constraints due to a general lack of awareness about the condition's symptoms and the long-term management necessities associated with it. Limited understanding of available therapeutic options among both dog owners and veterinary professionals can hinder timely diagnosis and effective treatment. If pet owners perceive the skin issue as trivial or not significant compared to other chronic conditions, they may forego veterinary consultations in favor of home remedies. This tendency to adopt a palliative approach further reduces the incentive for comprehensive diagnostic evaluations and prescription treatments, ultimately impeding the adoption of new therapies in the market.

Market Trends of the Global Canine Atopic Dermatitis Market

The Global Canine Atopic Dermatitis market is witnessing a significant trend towards precision veterinary therapies, highlighting the shift towards personalized and targeted treatment solutions. Innovations in biomarker-based diagnostics are enabling more effective immunomodulators and advanced topical formulations that cater to individual canine needs. Collaborative efforts between specialty veterinarians and pharmaceutical companies are enhancing the development of these targeted therapies, while integrative care models emphasize the importance of overall skin health and quality of life. This focus on customized treatment plans and preventive strategies is transforming the market landscape, offering distinct clinical differentiators and improved outcomes for affected dogs.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Canine Atopic Dermatitis Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Corticosteroids
• Cyclosporine
• Monoclonal Antibodies
• Antihistamines
• Immunotherapy
• Others

Global Canine Atopic Dermatitis Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Topical

Global Canine Atopic Dermatitis Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics & Hospitals
• Retail Pharmacies
• Online Pharmacies

Global Canine Atopic Dermatitis Market Size by Disease Severity & CAGR (2026-2033)

• Market Overview
• Mild
• Moderate
• Severe

Global Canine Atopic Dermatitis Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Pet Owners
• Veterinary Hospitals

Global Canine Atopic Dermatitis Market Size & CAGR (2026-2033)

• North America (Treatment Type, Route of Administration, Distribution Channel, Disease Severity, End-User)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Distribution Channel, Disease Severity, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Distribution Channel, Disease Severity, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Distribution Channel, Disease Severity, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Distribution Channel, Disease Severity, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindred Biosciences (Elanco)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (diagnostics overlap)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health (now part of Elanco)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetIQ Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Industries (biologics involvement)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dermcare-Vet Pty Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nextmune
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations